Association of EGFR mutations with ERCC1 expression in non-small cell lung cancer

    Journal of Clinical Oncology, 2017.

    Cited by: 0|Bibtex|Views0|

    Abstract:

    e19075 Background: Previously we presented some evidence that patients with EGFR mutations might be more sensitive to cytotoxic chemotherapies (namely platinum-based regimens) compared with wild type patients in advanced NSCLC. Thus, we sought to explore the underlying mechanism from the perspective of markers for chemotherapy sensitivity...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments